Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. NTES

Go back to Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
(NASDAQ: IMMX) Delayed: 13.16 -0.03 (0.23%)
Previous Close $13.19    52 Week High $ 
Open $12.98    52 Week Low $ 
Day High $13.20    P/E N/A 
Day Low $12.69    EPS $ 
Volume 1,666,197